We came across a bullish thesis on Hims & Hers Health, Inc. (HIMS) on Substack by Antonio Linares. In this article, we will ...

Investors with a lot of money to spend have taken a bullish stance on Hims & Hers Health (NYSE:HIMS). And retail traders should know. We noticed this today when the trades showed up on publicly ...

Investors with a lot of money to spend have taken a bullish stance on Hims & Hers Health HIMS. And retail traders should know. We noticed this today when the trades showed up on publicly available ...

Like other prescription medicines, Viagra and its generic form, sildenafil, work best when you take them under the right conditions. From your mental state to your eating habits, a range of ...

If you’re on the fence about investing in Hims & Hers Health, Inc., Privia Health Group or Inc. because you’re not sure how they measure up, it’s important to compare them on a few factors before ...

Hims & Hers (NYSE: HIMS) has been on a wild journey over the past year as GLP-1s drive both big gains and big losses for the stock. But the business is about much more than just one product, and ...

Millions of individuals around the world experience symptoms of erectile dysfunction (ED). But, for how common ED is, it can ...

Hims offers convenient and affordable access to treatments and products tailored for men’s health needs. But how much does it really cost to use this telehealth platform? This guide examines Hims’ ...

BTIG initiated coverage of Hims & Hers with a Buy rating and $35 price target The firm says its likes Hims & Hers because of its “disruptive” business model approach that delivers health ...

“Is this storm named Viagra?” joked another. They also shared a meme of the map with the caption, “If your storm lasts longer than four hours, call a physician”. “If that’s the size wh ...

Since labeling Hims & Hers a “generational” buy at $3.40 per share in May 2022, I have re-iterated my uber-bullish stance on HIMS stock — supported by impressive business performance from ...